Quantcast

Latest Gemifloxacin Stories

2009-07-13 16:35:00

CARY, N.C., July 13 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that it has signed a definitive asset purchase agreement with Oscient Pharmaceuticals Corporation (Nasdaq CM: OSCI) to acquire the commercial rights to the antibiotic Factive(R) (gemifloxacin mesylate) in North America and...

2008-07-08 15:00:56

The U.S. Food and Drug Administration says it's notified makers of fluoroquinolone antimicrobial drugs that a boxed warning is necessary for those products. The FDA said it is also requiring those manufacturers to provide a medication guide to patients about the increased risk of tendinitis and tendon rupture. Fluoroquinolones are effective in treating certain bacterial infections but healthcare professionals and patients need to be aware of the increased risk associated with the use of...

2004-11-30 18:00:11

Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the First Albany Capital Annual Growth Conference on December 7, 2004 in New York City. The Company's President and CEO, Steven Rauscher, will provide an overview of the Company as well as an update on the recent launch of FACTIVE(R) (gemifloxacin mesylate) tablets, the Company's lead product. The presentation will begin at 2:40 PM ET on Tuesday and will be webcast through the Company's website at www.oscient.com. An...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.